The global biosensors market is exhibiting robust growth, fueled by the escalating prevalence of chronic and lifestyle-induced diseases, the need for point-of-care testing, and advances in nanotechnology. According to Markets, the biosensors market is expected to reach approximately $36.7 billion by 2026, growing at a CAGR of 7.5% from 2021 to 2026. Biosensors' adaptability for integration into different devices and a rise in demand for glucose monitoring systems are key growth drivers. While regulatory hurdles and pricing pressure may challenge the growth, emerging markets and non-invasive biosensors offer significant opportunities for the industry.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by